Zafgen Appoints 20-Year Biotechnology Industry Veteran Patricia Allen, CPA, as Chief Financial Officer
1/4/2013 7:19:45 AM
More...
|
Zafgen Secures $21 Million in Series D Financing
12/4/2012 6:55:28 AM
More...
|
Zafgen Announces Initiation of Phase 2a Clinical Development with Beloranib in Obesity
11/6/2012 11:07:59 AM
More...
|
Zafgen Announces Additional Weight Loss and Cardiometabolic Data from Phase 1b Studies of Beloranib in Obesity at Obesity 2012, the 30th Annual Scientific Meeting of The Obesity Society
9/24/2012 10:34:26 AM
More...
|
Zafgen Appoints Business Development Veteran Frances K. Heller to Board of Directors
10/13/2011 9:49:29 AM
More...
|
Zafgen to Present at The Obesity Society 29th Annual Scientific Meeting
9/28/2011 10:02:58 AM
More...
|
Zafgen Appoints Industry Executive Dennis Kim, M.D., M.B.A., to Chief Medical Officer
9/21/2011 10:38:05 AM
More...
|
Zafgen Secures $33 Million Series C Financing
7/7/2011 6:41:06 AM
More...
|
Dalton Pharma Services and Zafgen Enter Into Aseptic Fill Services Agreement
5/16/2011 2:27:33 PM
More...
|
Zafgen to Present at BioCentury Future Leaders in the Biotech Industry Conference
4/8/2011 8:25:01 AM
More...
|
|